Unknown PHASE2 INTERVENTIONAL 1-arm NCT03008694

Effect of FDG-PET/CT for Simulation and Radiation Treatment Planning in Oral Cancer Patients

Phrase II Single Arm Study of Effect of FDG-PET/CT for Simulation and Radiation Treatment Planning in Oral

Sponsor: Zhongnan Hospital

Conditions Oral Cancer Radiotherapy; Complications

Interventions PET/CT

Updated 6 times since 2017 Last updated: Dec 29, 2016 Started: Jan 31, 2017 Primary completion: Dec 31, 2018 Completion: Jan 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Oral Cancer and Radiotherapy; Complications and is currently ongoing. Zhongnan Hospital leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Feb 2019 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Feb 2019 [monthly]

Not Yet Recruiting PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zhongnan Hospital

Data source: Zhongnan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.